CITIUS PHARMACEUTICALS
Citius Pharmaceuticals is a specialty pharmaceutical company dedicated to the development and commercialization of therapeutic products for large and growing markets. Citius products offer new and expanded indications for previously approved pharmaceutical products as a means to achieve leading market position or market exclusivity. By using previously approved drugs with substantial safety and efficacy data, Citius seeks to reduce the risks associated with pharmaceutical product development. Citius is currently advancing two proprietary product candidates, our Mino-Lokâ„¢ product and a Hydrocortisone-Lidocaine formulation. Citius believes the markets for its products are large and underserved by the current standard of care.
CITIUS PHARMACEUTICALS
Industry:
Biotechnology Life Science Medical Therapeutics
Founded:
2007-01-01
Address:
Cranford, New Jersey, United States
Country:
United States
Website Url:
http://www.citiuspharma.com
Total Employee:
11+
Status:
Active
Contact:
(908)967-6677
Email Addresses:
[email protected]
Total Funding:
144.9 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Domain Not Resolving
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
immatics biotechnologies
immatics is a biopharmaceutical company focused on the development of immunotherapeutic substances for cancer therapy.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2016-04-04 | Leonard-Meron Biosciences | Leonard-Meron Biosciences acquired by Citius Pharmaceuticals | N/A |
Investors List
Leonard Mazur
Leonard Mazur investment in Post-IPO Equity - Citius Pharmaceuticals
Myron Holubiak
Myron Holubiak investment in Post-IPO Equity - Citius Pharmaceuticals
Key Employee Changes
Date | New article |
---|---|
2021-11-05 | Citius Pharmaceuticals Expands Management Team with Appointment of Kelly Creighton, PhD as Executive Vice President of Chemistry, Manufacturing and Controls |
Official Site Inspections
http://www.citiuspharma.com Semrush global rank: 2.51 M Semrush visits lastest month: 7.02 K
Unable to get host informations!!!